The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 28, 2018
Filed:
Mar. 31, 2016
Applicant:
Astellas Pharma Inc., Tokyo, JP;
Inventors:
Seiji Takae, Tokyo, JP;
Toshiro Sakai, Tokyo, JP;
Yuki Kasashima, Tokyo, JP;
Yurina Ansei, Tokyo, JP;
Tsuyoshi Kiyota, Tokyo, JP;
Assignee:
ASTELLAS PHARMA INC., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61K 31/167 (2006.01); A61K 47/12 (2006.01); A61K 9/10 (2006.01); A61K 47/36 (2006.01); A61K 47/50 (2017.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 9/10 (2013.01); A61K 31/167 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/50 (2017.08);
Abstract
To provide: (1) a modified release liquid (suspension) containing mirabegron, (2) a ready-to-suspend pharmaceutical composition containing mirabegron, and (3) a mirabegron-containing pharmaceutical composition that does not generate undissolved lumps, even when it is suspended at the time of use. The present invention relates to a pharmaceutical composition containing a complex of mirabegron or a pharmaceutically acceptable salt thereof with sodium polystyrene sulfonate.